Back
Apellis Pharmaceuticals Vs. NuScale Power Industry Stock Comparison
Sell
28
APLS
Apellis Pharmaceuticals
Last Price:
$18.74
Seasonality Move:
-8.3%
Buy
66
SMR
NuScale Power
Last Price:
$51.03
Seasonality Move:
4.3%
Sell
28
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
-
The current Apellis Pharmaceuticals [APLS] share price is $18.75. The Score for APLS is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
-
APLS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
66
NuScale Power (SMR)
is a Buy
Is NuScale Power a Buy, Sell or Hold?
-
The current NuScale Power [SMR] share price is $51.67. The Score for SMR is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
-
SMR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $18.75Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing selling pressure, which indicates risk of future bearish movement.
SMR Stock Price Chart
What is NuScale Power's stock price today?
-
The NuScale Power share price today is $51.67Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SMR is experiencing slight selling pressure.
APLS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.32 | Buy |
| Relative Strength Index (14 RSI): | 47.23 | Sell |
| Chaikin Money Flow: | -2535129 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.93 - 19.77) | Sell |
| Bollinger Bands (100): | (17.17 - 22.37) | Sell |
SMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 12.41 | Buy |
| Relative Strength Index (14 RSI): | 68.64 | Buy |
| Chaikin Money Flow: | 6821911 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
APLS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.63 | Sell |
| 20-day SMA: | 19.04 | Sell |
| 50-day SMA: | 18.49 | Buy |
| 200-day SMA: | 24.78 | Sell |
| 8-day EMA: | 19.47 | Sell |
| 20-day EMA: | 19.2 | Sell |
| 50-day EMA: | 19.11 | Sell |
| 200-day EMA: | 25.19 | Sell |
SMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.95 | Buy |
| 20-day SMA: | 41.72 | Buy |
| 50-day SMA: | 36.69 | Buy |
| 200-day SMA: | 23.91 | Buy |
| 8-day EMA: | 46.44 | Buy |
| 20-day EMA: | 34.46 | Buy |
| 50-day EMA: | 19.12 | Buy |
| 200-day EMA: | 5.75 | Buy |
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.38 per share, a decrease next quarter of $0.39 per share, an increase this year of $0.45 per share, and an increase next year of $0.39 per share.
NuScale Power Earnings Growth & SMR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.56 per share, and an increase next year of $0.03 per share.
Apellis Pharmaceuticals Technical Analysis
| Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | Jul 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 15 | 16 | 17 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NuScale Power Technical Analysis
| Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | Jul 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 15 | 16 | 17 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||